Combination Hormone/Vaccine Therapy for Prostate Cancer May Benefit Patients Whose Disease Returns A new study finds that a cancer vaccine combined with hormone-deprivation therapy can help patients with recurrence of prostate cancer. The results of this clinical trial, led by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, appear in the August 2005 issue of the Journal of Urology Jul 25, 2005, 07:34
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment